INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
IRS1 | Insulin receptor substrate 1 | Disease related genes Plasma proteins
| | | | | Mixed |
IRS2 | Insulin receptor substrate 2 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
IGF1R | Insulin-like growth factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
IGF1 | Insulin-like growth factor 1 (somatomedin C) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
IGFBP3 | Insulin-like growth factor binding protein 3 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IDE | Insulin-degrading enzyme | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
IGF2 | Insulin-like growth factor 2 (somatomedin A) | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
GRB10 | Growth factor receptor-bound protein 10 | Cancer-related genes
| | | | | Expressed in all |
INSRR | Insulin receptor-related receptor | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PTPN1 | Protein tyrosine phosphatase, non-receptor type 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
SORBS1 | Sorbin and SH3 domain containing 1 | | | | | | Expressed in all |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
IGF2R | Insulin-like growth factor 2 receptor | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
IRS4 | Insulin receptor substrate 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
PRKCZ | Protein kinase C, zeta | Enzymes Plasma proteins
| | | | | Mixed |
PTPN11 | Protein tyrosine phosphatase, non-receptor type 11 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
PDX1 | Pancreatic and duodenal homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enriched |
PHIP | Pleckstrin homology domain interacting protein | | | | | | Expressed in all |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GCK | Glucokinase (hexokinase 4) | Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
GIP | Gastric inhibitory polypeptide | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GPLD1 | Glycosylphosphatidylinositol specific phospholipase D1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IGFBP4 | Insulin-like growth factor binding protein 4 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
KCNJ11 | Potassium inwardly-rectifying channel, subfamily J, member 11 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
LEP | Leptin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SREBF1 | Sterol regulatory element binding transcription factor 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
IGFBP5 | Insulin-like growth factor binding protein 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
INPPL1 | Inositol polyphosphate phosphatase-like 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
INSIG2 | Insulin induced gene 2 | Predicted membrane proteins
| | | | | Expressed in all |
INSL3 | Insulin-like 3 (Leydig cell) | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
AKT2 | V-akt murine thymoma viral oncogene homolog 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | | Expressed in all |
C2CD5 | C2 calcium-dependent domain containing 5 | | | | | | Expressed in all |
CIDEC | Cell death-inducing DFFA-like effector c | Disease related genes
| | | | | Tissue enriched |
GCG | Glucagon | Predicted secreted proteins
| | | | | Tissue enriched |
GHRL | Ghrelin/obestatin prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GIPR | Gastric inhibitory polypeptide receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GSK3A | Glycogen synthase kinase 3 alpha | Cancer-related genes Enzymes
| | | | | Expressed in all |
INPP5K | Inositol polyphosphate-5-phosphatase K | Enzymes
| | | | | Expressed in all |
INSL5 | Insulin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
INSL6 | Insulin-like 6 | Predicted secreted proteins
| | | | | Tissue enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |